Peptides DB
Research-centric peptide and protocol reference hub

GLP-1 Blends record · updated 17h ago

Metabolic & appetiteNeuro & moodGrade A · human clinicalResearch use only
All 7 studiesJump to the evidenceCompare
What is GLP-1 Blends used for?

GLP-1 blends refer to combinations of glucagon-like peptide-1 (GLP-1) analogs or related compounds that may enhance the secretion of this hormone, which plays a critical role in glucose metabolism and appetite regulation. Recent research has explored various natural extracts and dietary components that may influence GLP-1 secretion and its physiological effects.

How it works: GLP-1 receptor agonist

Primarily researched for · Metabolic & appetite

Development stage

where GLP-1 Blends sits between preclinical work and regulatory approval
  1. 1Current
    Preclinical
    Animal / in-vitro work
  2. 2Not reached
    Phase 1
    Safety in humans
  3. 3Not reached
    Phase 2
    Efficacy signal
  4. 4Not reached
    Phase 3
    Confirmatory trials
  5. 5Not reached
    Approved
    Cleared by a regulator

Stage is inferred from the highest trial phase in the indexed corpus and 68 registered trials. It describes the research record, not a recommendation.

Identity
NameGLP-1 Blends
Chain length—
Molecular weight—
Formula—
Structure type—
ClassMetabolic
Research levelModerate Research
Discovered byAdded before provenance tracking · 2025
Pharmacology
MechanismGLP-1 receptor agonist
Route—
Half-life—
Time to peak—
Duration—
Extraction confidence0.50
Effect profile · 0–5
These seven scores are generated by the Librarian — an autonomous agent running GPT-4o over the indexed studies, trials and label data for this compound. No human assigns them and no community vote moves them. Last recomputed Jul 27, 2026. How this works →
Research stats
Total studies7
Human / animal / cellular1 / 0 / 2
Highest trial phasePreclinical
Years covered2010–2026
Latest study1mo ago
Publication history
20102026
Research funding
572 NIH projects · $16.4M awarded · through FY2026
Public grants naming this compound. Funding is interest, not evidence.
Safety signals
FAERS reportsnone recorded
Serious AEs in animal work—
Community reports—
Positive —Neutral —Negative —
Records

Study register

7 rowsOpen in the library →
StudyTypeYearSummary depth
Dietary fiber in pediatric gastrointestinal health: a narrative review of evidence and challenges.
Finding80%-90% of children fail to meet recommended daily fiber intake levels of approximately 14-31 g/day.
review2026Full text read0.80
An effort to enhance the clinical translatability of caprate-based tablet formulations in gastric peptide delivery.
Finding57% increase in exposure compared to the benchmark SNAC formulation in animal studies 0.5 h post dosing.
review2026Full text read0.70
Navigating the potential of algal peptides: health effects, market applications, and scientific challenges.
FindingNot reported in abstract.
review2026Full text read0.70
The Acute Effect of Consuming Whey Versus a Plant-Based Protein Blend on Postprandial Metabolism and Appetite in a Sample of Healthy Adults.
FindingHigher insulin concentrations at T30 for whey, p<0.001.
Human2026Full text read0.80
Semantic Scholar search for GLP-1 Blends
TakeawayNot reported in abstract.
—2010Title only0.00
In Vitro Assessment of the Bioaccessibility and Hypoglycemic Properties of Essential Amino Acids Blend: Implication for Diabetes Management.
FindingNot reported in abstract.
In vitro2025Partial text0.60
Combination of Citrus aurantifolia Fruit Rind and Theobroma cacao Seed Extracts Stimulates Glucagon-Like Peptide-1 Secretion by Activating hTAS2Rs and the Phospholipase C-Mediated Signaling Pathway in NCI-H716 Cells.
FindingLN19183 increased relative GLP-1 secretion dose-dependently, reaching statistical significance at 50 µg/mL (p<0.05).
In vitro2025Full text read0.70

What people are saying

anecdotal · not evidence

Unverified first-hand accounts from public forums. These are not studies: nobody checked what was taken, whether it was what the label said, or what else was going on. They count for nothing in the evidence grade above and are shown because a reader searching GLP-1 Blends will meet them anyway, and meeting them next to a graded evidence base is better than meeting them alone.

Community collection has not run yet, so this is an empty shelf rather than a quiet one — nothing has been read, and no conclusion about how much GLP-1 Blends is discussed should be drawn from it.